Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7505459 | Drug and Alcohol Dependence | 2014 | 11 Pages |
Abstract
For these reasons, and given the complexities of studies on this issue and comorbid problems, we conclude that fixed, arbitrary limits on BUP doses in clinical care or limits on reimbursement for this care are unwarranted.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Mark K. Greenwald, Sandra D. Comer, David A. Fiellin,